SCHEMBL8859092

SCHEMBL8859092

O=C(O)C1CCCN(CCOCCN2c3ccccc3Oc3ccccc32)C1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
SLC6A1 P30531 4/20 0.75

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8859088 1.00 SLC6A1 (0.75) SLC6A1
Hydrochloric Acid SCHEMBL8859051 0.99 SLC6A1 (0.74) SLC6A1
Hydrochloric Acid SCHEMBL8859062 0.99 SLC6A1 (0.74) SLC6A1
SCHEMBL7609595 0.90 SLC6A1 (0.60) SLC6A1
SCHEMBL7609592 0.90 SLC6A1 (0.60) SLC6A1
Hydrochloric Acid SCHEMBL8201670 0.89 SLC6A1 (0.59) SLC6A1
Hydrochloric Acid SCHEMBL8201665 0.89 SLC6A1 (0.59) SLC6A1
SCHEMBL8859052 0.86 SLC6A1 (1.00) SLC6A1
SCHEMBL8859064 0.86 SLC6A1 (1.00) SLC6A1
SCHEMBL9086198 0.85 SLC6A1 (0.55) SLC6A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0735872-A1 A METHOD OF TREATING NEUROGENIC INFLAMMATION NOVO NORDISK A/S (DK) 1996-10-09 EP claimed
EP-0585314-B1 NOVEL HETEROCYCLIC CARBOXYLIC ACIDS NOVO NORDISK AS (DK) 1996-09-18 EP claimed
WO-1995018615-A1 A METHOD OF TREATING NEUROGENIC INFLAMMATION NOVO NORDISK A/S (DK) 1995-07-13 WO claimed
WO-1997022342-A1 NOVEL METHOD NOVO NORDISK A/S (DK) 1997-06-26 WO disclosed